PRDM9 and central nervous system cancer: In addition, the epigenetic inactivation of the histone methyltransferase NSD1 leads to the specifically diminished methylation of the histone lysine residues H3K36 and increases the expression of oncogene MEIS1 in human neuroblastoma and glioma [38].